Biotage AB (publ) (0GRP.L)

216,59 +4,79 (+2,26%) Alla chiusura: 05:13PM BST

Biotage AB (publ)

Vimpelgatan 5
Box 8
Uppsala 751 03
Sweden
46 18 56 59 00
https://www.biotage.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 669

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Torben Jorgensen B.Sc.	CEO, President & Director	857k	N/D	1952
Mr. Andrew Kellett	Chief Financial Officer	N/D	N/D	1969
Mr. Anders Wikstrom BSc, CS	Executive Vice President of Operations	N/D	N/D	1973
Raffaella Bombarda	EVP of Global Marketing	N/D	N/D	1974
Ms. Petra Duprez	Chief Human Resources & Sustainability Officer	N/D	N/D	1965
Mr. Scott Carr	President of Americas & Chief/Head of Americas	N/D	N/D	1967
Mr. Jonas Stahlberg	Chief Auditor	N/D	N/D	1975
Mr. Olof Nord	Executive Vice President of Business Development	N/D	N/D	1975
Mr. Andreas Juhlin	President of International - EMEA and APAC	N/D	N/D	1974
Mr. Magnus Nordstedt	Executive Vice President of IT & Digitalization	N/D	N/D	1970

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in SEK.

Descrizione

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.

Governance aziendale

L'ISS Governance QualityScore di Biotage AB (publ) al 1 maggio 2024 è 7. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 9; diritti degli azionisti: 8; retribuzione: 1.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.